A San Francisco federal jury made more than $ 80 million available to a 70-year-old California man after finding last week that his handling of Monsanto's widespread weed killer Roundup was a major factor in the development of his cancer was.
The announced verdict on Wednesday announced the second and final phase of the lawsuit in a lawsuit by Edwin Hardeman against Monsanto, the maker of the widely-used herbicide.
The jurors once again opted for Hardeman and said that Monsanto was purchased last year by Bayer AG for $ 63 billion for the man in Sonoma County, because he was not sufficiently protected from the dangers of using the glyphosate -based weed killer warned.
Hardeman received $ 75 million in punitive damages and approximately $ 5.8 million in damages.
"As demonstrated throughout the process, Monsanto has been refusing to act responsibly since the formation of Roundup over 40 years ago," said Hardeman lawyers Aimee Wagstaff and Jennifer Moore d in a joint statement. "Today, the jury has blamed Monsanto for 40 years of abuse and told Monsanto that it needs to change the way it conducts business."
Hardeman was diagnosed with non-Hodgkin's lymphoma in February 201
The lawsuit alleged that Hardeman's longstanding exposure to Roundup caused his cancer and that Monsanto knew or should not have been aware of the risks, risks, or any adequate warnings of the harm associated with using the product.
Hardeman's lawsuit is the main case of a multiple district litigation involving more than 1,600 plaintiffs before the US District Court for the Northern District of California, and the second case claiming Monsanto's glyphosate causes -based products Krebs, who has gone to court.
In August 2018, a jury in the California federal court awarded a man with end-stage cancer He worked as a schoolyard owner, paying nearly $ 290 million in damages. The verdict was later reduced to $ 78.5 million and is appealed.
Bayer said Wednesday it will also appeal the Hardeman case. The German pharmaceutical company also claimed that the herbicide was safe.
"We are disappointed with the jury's decision, but this ruling does not change the meaning of over four decades of science and the conclusions of regulators worldwide who support the safety of our glyphosate-based herbicides and are not carcinogenic "Bayer said in a statement. "We have great understanding for Mr. Hardeman and his family, and Bayer stands behind these products and will vigorously defend them."
Together, the two judgments at federal and federal levels form a powerful precedent for thousands of other pending cases of the courts. In January, Monsanto was confronted with claims from more than 11,000 plaintiffs who alleged that they had been harmed by glyphosate-based products, according to Bayer
. In 2015, the World Health Organization's International Cancer Research Organization classified glyphosate as a likely carcinogen to humans, but the US Environmental Protection Agency (EPA) has concluded that the herbicide is not carcinogenic to humans.
Glyphosate-based products are not banned in some cities in the United States Throughout the country, jurisdictions have taken steps to ban or restrict the use of the herbicide, and in 2017 California issued a warning for the chemical and added them to the list of substances known to cause cancer.
In the second phase of In the Hardeman study, the jury learned that Monsanto knew epidemiological studies, animal studies and genotoxicity studies that showed a link between Roundup and the non-Hodgkins study ymphoma.
The jury also heard evidence that the agrochemical giant went so far as to write scientific writings, according to court documents.
"If you look at Monsanto's internal documents, they realize that they knew that too, and they decided not to inform the American public, and they did not want to tell the world that their product was dangerous." Moore said during a press conference after the verdict. "The jury today unanimously decided that this is wrong, that it is fraudulent and vicious."